Prostate Cancer Clinical Trial

Lycopene in Preventing Prostate Cancer in Healthy Participants

Summary

RATIONALE: Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from forming.

PURPOSE: This randomized clinical trial is studying how well lycopene works in preventing prostate cancer in healthy participants.

View Full Description

Full Description

OBJECTIVES:

Primary

Determine whether lycopene supplementation affects percent free and bound prostate-specific antigen (PSA) in healthy participants.

Secondary

Determine whether lycopene reduces oxidative stress in these participants, as indicated by lipid peroxidation assay.
Determine whether a 21-day washout period is sufficient to return lycopene, PSA, and lipid peroxidation products to baseline.

OUTLINE: This is a randomized, placebo-controlled study. Participants are randomized to 1 of 3 treatment arms.

Arm I: Participants receive an oral tomato dietary supplement containing lycopene twice daily for 3 weeks.
Arm II: Participants receive an oral tomato dietary supplement containing lycopene at a higher dose twice daily for 3 weeks.
Arm III: Participants receive oral placebo twice daily for 3 weeks. Urine and blood samples are collected on days 0, 21, and 42.

PROJECTED ACCRUAL: A total of 150 participants will be accrued for this study.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Healthy participants
No existing prostate disease

PATIENT CHARACTERISTICS:

Able to supply blood and urine samples
Able to answer demographic and dietary recall questionnaires
No hospital inpatients
Not allergic to tomatoes or tomato products
Not abusing alcohol or non-prescribed drugs
No existing gastrointestinal disease or cancer

PRIOR CONCURRENT THERAPY:

At least 2 weeks since prior lycopene (in supplement form)
No concurrent participation in another clinical trial

Study is for people with:

Prostate Cancer

Estimated Enrollment:

150

Study ID:

NCT00322114

Recruitment Status:

Unknown status

Sponsor:

University of Illinois at Chicago

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Illinois Cancer Center
Chicago Illinois, 60612, United States More Info
Clinical Trial Office - University of Illinois Cancer Center
Contact
312-355-3046

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

150

Study ID:

NCT00322114

Recruitment Status:

Unknown status

Sponsor:


University of Illinois at Chicago

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider